...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience
【24h】

Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience

机译:Dapagliflozin在同时接受二甲双胍的2型糖尿病患者中的疗效和肾脏安全性:真实生活体验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction. This study aimed at evaluating the efficacy and safety of dapagliflozin in patients with type 2 diabetes (T2D) who also received metformin in clinical practice in Italy. Methods. This was a retrospective observational study and it included data from patients who received dapagliflozin 10 mg once daily in conjunction with metformin for 12 months (DAPA 
机译:介绍。这项研究旨在评估达格列净对2型糖尿病(T2D)患者的疗效和安全性,这些患者在意大利的临床实践中也接受了二甲双胍。方法。这是一项回顾性观察性研究,其中包括每日一次接受达格列净10μmg联合二甲双胍治疗12个月的患者的数据(DAPA)

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号